These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 9558034
1. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer. Kovacs TO, Campbell D, Haber M, Rose P, Jennings DE, Richter J. Dig Dis Sci; 1998 Apr; 43(4):779-85. PubMed ID: 9558034 [Abstract] [Full Text] [Related]
2. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists. Kovacs TO, Campbell D, Richter J, Haber M, Jennings DE, Rose P. Aliment Pharmacol Ther; 1999 Jul; 13(7):959-67. PubMed ID: 10383532 [Abstract] [Full Text] [Related]
3. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer. Avner DL, Movva R, Nelson KJ, McFarland M, Berry W, Erfling W. Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232 [Abstract] [Full Text] [Related]
4. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B, NSAID-Associated Gastric Ulcer Prevention Study Group. Arch Intern Med; 2002 Jan 28; 162(2):169-75. PubMed ID: 11802750 [Abstract] [Full Text] [Related]
5. Effects of lansoprazole on gastric ulcer healing and mucin content. Komuro Y, Ishii K, Miyake Y, Tanabe S, Oida M, Saigenji K. J Clin Gastroenterol; 1995 Jan 28; 20 Suppl 2():S47-51. PubMed ID: 7594339 [Abstract] [Full Text] [Related]
6. Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group. Lanza F, Goff J, Silvers D, Winters J, Jhala N, Jennings D, Greski-Rose P. Dig Dis Sci; 1997 Dec 28; 42(12):2529-36. PubMed ID: 9440632 [Abstract] [Full Text] [Related]
7. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group. Avner DL, Dorsch ER, Jennings DE, Greski-Rose PA. Aliment Pharmacol Ther; 1995 Oct 28; 9(5):521-8. PubMed ID: 8580272 [Abstract] [Full Text] [Related]
8. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa. Arroyo Villarino MT, Lanas Arbeloa A, Esteva Díaz F, Ortego Fernández de Retana J, Sainz Samitier R. Rev Esp Enferm Dig; 1997 May 28; 89(5):347-56. PubMed ID: 9190140 [Abstract] [Full Text] [Related]
9. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P. Am J Gastroenterol; 1994 Aug 28; 89(8):1191-200. PubMed ID: 8053433 [Abstract] [Full Text] [Related]
10. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial. Michel P, Lemaire M, Colin R, Bommelaer G, Rambaud JC, Dupas JL, Bigard MA, Verwaerd JC. Aliment Pharmacol Ther; 1994 Feb 28; 8(1):119-22. PubMed ID: 8186337 [Abstract] [Full Text] [Related]
11. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL, Huang B, Amer F, Christopoulos NG. Clin Ther; 2004 Oct 28; 26(10):1637-43. PubMed ID: 15598480 [Abstract] [Full Text] [Related]
12. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer]. Ogawa N. Nihon Rinsho; 1992 Jan 28; 50(1):68-73. PubMed ID: 1347332 [Abstract] [Full Text] [Related]
13. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial. Russo A, Dattilo M. Ital J Gastroenterol Hepatol; 1997 Aug 28; 29(4):312-9. PubMed ID: 9476183 [Abstract] [Full Text] [Related]
14. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome. Hirschowitz BI, Mohnen J, Shaw S. Aliment Pharmacol Ther; 1996 Aug 28; 10(4):507-22. PubMed ID: 8853754 [Abstract] [Full Text] [Related]
15. A trial of lansoprazole in refractory gastric ulcer. van Rensburg CJ, Louw JA, Girdwood AH, Simjee AE, Marks IN. Aliment Pharmacol Ther; 1996 Jun 28; 10(3):381-6. PubMed ID: 8791967 [Abstract] [Full Text] [Related]
16. Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration? Hoshino E, Umeda N, Sano J, Miki K, Yahagi N, Oka M, Kimura M, Miyashita H. J Clin Gastroenterol; 1995 Jun 28; 20 Suppl 2():S72-4. PubMed ID: 7594346 [Abstract] [Full Text] [Related]
17. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer]. Ramón Nogueira J, Esquivel Ayanegui F, Esquivel Rodríguez F, Sáenz V, Santoyo R. Rev Gastroenterol Mex; 1996 Jun 28; 61(4):314-9. PubMed ID: 9072782 [Abstract] [Full Text] [Related]
18. Rapid healing of gastric ulcers with lansoprazole. Bardhan KD, Ahlberg J, Hislop WS, Lindholmer C, Long RG, Morgan AG, Sjostedt S, Smith PM, Stig R, Wormsley KG. Aliment Pharmacol Ther; 1994 Apr 28; 8(2):215-20. PubMed ID: 8038354 [Abstract] [Full Text] [Related]
19. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors. Tsukamoto Y, Goto H, Hase S, Niwa Y, Arisawa T, Hayakawa T, Yoshikane H. J Clin Gastroenterol; 1995 Apr 28; 20 Suppl 2():S40-3. PubMed ID: 7594337 [Abstract] [Full Text] [Related]